February 11, 2022 Columns by Ed Tobias What Is Trigeminal Neuralgia in MS All About, Anyway? My immediate thought after reading a recent MS News Today headline stating that trigeminal neuralgia (TN) affects more than 3% of MS patients was, “Really, only 3%?” The reason is I’ve seen several complaints about the condition, which causes excruciating pain in the face. As the story noted, TN…
February 7, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Predicting Disease Progression, Temelimab, Trigeminal Neuralgia Combined Data May Predict Personās Risk of Advancing From CIS to MS Clinically isolated syndrome is sometimes called “early MS.” It’s the diagnosis used when someone’s symptoms don’t quite look like MS, but it does appear that MS is lurking. It may take years for an actual…
February 4, 2022 Columns by Ed Tobias Taking Another Look at Vitamin D, Immune Tolerance, and MS I’ve been popping vitamin D pills for years ā decades, really. I never really understood why, I just knew that many people with multiple sclerosis (MS) are vitamin D-deficient. A recent study has cast some new light on why I should continue. It all seems to comes down to…
January 31, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: COVID-19 Booster, EBV Treatment, Childhood MS Risks, Vitamin D COVID-19 Booster May Benefit Patients on Anti-CD20 Therapy After multiple reports of how Gilenya and anti-CD20 MS medications reduce the efficacy of the mRNA COVID-19 vaccines, here’s more evidence that a booster shot may improve that protection. The researchers report “modestly increased levels” of antiāSARS-CoV-2 antibodies after a third…
January 28, 2022 Columns by Ed Tobias MS Hiker Laces Up Her Boots for Appalachian Trail Reservations at a base lodge have been made, and a starting date is circled on her calendar. MS hiker April Hester is ready to start up the Appalachian Trail in the eastern U.S. It’s always an uphill hike for April, even when the trail is flat. She was diagnosed with…
January 24, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: MRSI, Acthar Gel, Tecfidera vs. Gilenya, Exergames Imaging Brain Metabolites May Help Diagnose, Monitor MS Have you ever heard of magnetic resonance spectroscopic imaging, or MRSI? I hadn’t until I read this story. It’s a technique that in concept allows a radiologist to see metabolites in the brain. Metabolites are small molecules that are produced during…
January 21, 2022 Columns by Ed Tobias An Epstein-Barr Virus Primer for MS Patients You may have heard about the research that’s just been published about the Epstein-Barr virus (EBV) and multiple sclerosis (MS). The Harvard T.H. Chan School of Public Health study reports that being infected by EBV raises the risk of developing MS by 32 times. This isn’t a small or…
January 17, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Epstein-Barr Virus, EHP-101, Anti-CD20 Therapies, Gut Bacteria Epstein-Barr Virus May be Leading Cause of MS, Raising Risk by 32 Times Several studies over the past few years have suggested a link between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), but this one is huge, both in the number of participants and in the length…
January 14, 2022 Columns by Ed Tobias Aquatic Therapy for Chronic Back Pain Multiple sclerosis (MS) has gotten to be a real pain in the back. In the past couple years, I’ve developed pain in a few areas of my body, especially my butt and back. Last winter, I tried physical therapy, but relief lasted only a short while. So, I think I’ll…
January 10, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Lemtrada, Music and White Matter, Diagnosing MS AB Science OKād to Start Masitinib Phase 3 Trial for Progressive MS Many of us with multiple sclerosis (MS) have been waiting for another treatment for progressive forms of MS. I hope this brings us another step closer to one. Masitinib is an oral medication that works by blocking…
January 7, 2022 Columns by Ed Tobias More Answers About COVID-19 Vaccines and MS A little over a year ago, I wrote about whether people with multiple sclerosis (MS) should get a COVID-19 vaccine. I was anxious to be vaccinated as soon as I could, but I was also concerned about how the vaccines would affect someone with MS. Would the side effects…
January 3, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Cortrophin Gel, Simvastatin, COVID-19 Treatments Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime Cortrophin Gel is similar to Achtar Gel, which was, until the U.S. Food and Drug Administration’s recent re-approval of Cortrophin, the only repository corticotropin injection available in the U.S. Cortrophin Gel is a naturally produced cortisol that is expected…
December 20, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: COVID-19 Vaccines, Achtar Gel, Ublituximab, Pregnancy Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines This research adds more evidence to studies that have already shown that certain disease-modifying therapies reduce the effectiveness of COVID-19 vaccines. Those DMTs include Kesimpta (ofatumumab) and Ocrevus (ocrelizumab), plus rituximab, another anti-CD20 vaccine, that is sometimes used…
December 17, 2021 Columns by Ed Tobias Sun-seeking Finds Support in New Study I’m back in Florida for the next several months, having left cloudy, windy, chilly Maryland for the Gulf Coast. It’s been sunny and in the low 80s for the past few days, and my multiple sclerosis (MS) is feeling just fine. A lot of people with MS avoid the heat,…
December 13, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: DMTs and Age, Lyvispah, Cells Driving MS, Melatonin Worsening of Disability Evident in Older Patients Who Stop DMTs Some neurologists believe that multiple sclerosis (MS) progression slows, or even stops, when people reach their 60s, so they advise patients that there’s no need to continue their disease-modifying therapies (DMTs). Personally, I think a DMT age ceiling is…
December 10, 2021 Columns by Ed Tobias I’m Back on the MS ‘Bladder Coaster’ I thought I finally had this bladder thing licked. After years of urinary urgency and frequency, I’d been doing much better. I was sleeping at least seven hours a night without having to go to the bathroom, and bathroom trips were less frequent in the daytime, too. When traveling…
December 6, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Vitamin D Deficiency, Emotions, Neurostimulation Vitamin D Deficiency Linked to Early Cognitive Issues in Study I’ve taken a vitamin D supplement for many years because numerous studies have shown a correlation between low vitamin D levels and MS. My levels have been normal for years, and I assume the supplement has helped. Even so,…
December 3, 2021 Columns by Ed Tobias My Lemtrada Treatment, 5 Years Later It was five years ago, Dec. 5, 2016, that I scootered into the office of Dr. Heidi Crayton, my neurologist, and plopped into a soft, brown leather recliner. Day 1 of Round 1 of my Lemtrada (alemtuzumab)Ā infusions was about to begin. I’d prepped for this day: two days…
November 29, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test First Patient Dosed in Phase 1 Trial of IMS001 Therapy IMS001 is an investigational treatment that uses mesenchymal stem cells (MSC) ā cells derived from human embryos. Preclinical studies have shown that IMS001 has the ability to stabilize an overactive immune system, as is the case in people with…
November 22, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Neural Sleeve, Supplements, Ocrevus, Cladribine Injection Wearable āNeural Sleeveā Counters Foot Drop, Aids Mobility in Study This is a neat concept, described by the manufacturer as a lightweight sleeve on the lower leg that predicts the movement a leg is about to make. Then it sends a signal to the muscles to help lift that…
November 19, 2021 Columns by Ed Tobias Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS? There are continuing signals that the Epstein-Barr virus (EBV) is a fuel that can spark a multiple sclerosis (MS) fire. EBV is a herpes virus that causes infectious mononucleosis, more commonly known as mono. Sometimes called the “kissing disease” because the virus that causes it is easily spread through saliva,…
November 15, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: NVG-291, Ocrevus, Tolebrutinib, Tecfidera Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People This experimental therapy has a long way to go before it becomes reality. But it’s encouraging that this first step found NVG-291’s side effects to be mild and short-lasting. NVG-291 is designed to promote remyelination by modulating an enzyme called…
November 12, 2021 Columns by Ed Tobias I’m Sleeping Better These Days, but Why? I had a great night’s sleep the other night. I fell asleep quickly and slept straight through the night for nearly seven hours. When I got up in the morning, I felt refreshed, which is exceedingly rare these days. Plus, it even happened a few more times in the past…
November 8, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Acthar Gel, Alcohol and MS Risk, Mindfulness Analysis Finds Acthar Gel Cost-effective for MS Relapses I’ve seen social media posts from people with MS who use Acthar Gel and report that it helps with their spasticity. The gel, which is a shot, not an ointment, prompts the body to creates cortisol, a steroid hormone that helps…
November 5, 2021 Columns by Ed Tobias I’m Grateful for My COVID-19 Booster Shot I’m hurtin’ a little today. I have mild muscle aches, a bit more fatigue than usual, and dragging legs. It could just be a bad MS day, or it could be the result of my COVID-19 booster shot a couple days ago.Ā I received a third shot of the Moderna…
November 1, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Mono and MS, Cold and Inflammation, Mesenchymal Stem Cells, MS Smartwatch Mono as Child or Teenager Tied to Risk of MS as Adult in Large Study There’s been a lot of buzz about this study, but I don’t think anyone should be surprised about its results. For years, researchers have suspected a link between the Epstein-Barr virus (EBV) ā the…
October 29, 2021 Columns by Ed Tobias Researchers Lower the Temperature to Try to Reduce MS Inflammation I hate the cold. It triggers my bladder and stiffens my legs. When the leaves start to turn in Maryland, I start thinking about the warm weather in Florida. So, I was interested to read research from the University of Geneva that indicates that exposure to cold…
October 25, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: AHSCT, Ocrevus, CD20 T-cells, Spasticity App National MS Society Supports Stem Cell Transplant for Select, Aggressive RRMS Bravo! This statement is welcome after the recommendation of National Multiple Sclerosis Society advisers that autologous hematopoietic stem cell transplant, or AHSCT, could be useful for people younger than 50 and recently diagnosed with MS. Now, how long…
October 22, 2021 Columns by Ed Tobias It’s Flu Vaccine Time Again, So Here’s What You Need to Know A couple weeks ago, my wife and I rolled up our sleeves and got our shots again. No, not the COVID-19 vaccine. We’ve already had two of those, and expect to receive a third before Thanksgiving. The latest shot was a seasonal flu vaccine, which we’ve gotten every year…
October 18, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: AHSCT for SPMS, Rituximab, Sativex, Smoking This week’s column focuses on stories from Multiple Sclerosis News Today reporters who have been following the annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, or ECTRIMS. #ECTRIMS2021 ā Stem Cell Transplant May Better Treat SPMS Than DMTs This presentation involves autologous…